William Jason Cummings

Title: William Jason Cummings: Innovator in Monoclonal Antibodies

Introduction

William Jason Cummings is a notable inventor based in Bellevue, WA (US). He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work focuses on advancing methods for detecting complement factor D, which plays a crucial role in the immune response.

Latest Patents

Cummings holds a patent for "Monoclonal antibodies, compositions and methods for detecting complement factor D." This patent discloses monoclonal antibodies that specifically bind to human mature Factor D and do not bind to human Pro-Factor D. Additionally, it includes antibodies that specifically bind to human Pro-Factor D and do not bind to human mature Factor D. The patent also covers methods for using these antibodies to detect the status of the Alternative Pathway of Complement (APC) in biological samples.

Career Highlights

William Jason Cummings is associated with Omeros Corporation, where he continues to contribute to innovative research in the field of monoclonal antibodies. His work has implications for understanding and treating various diseases related to the immune system.

Collaborations

Cummings has collaborated with notable colleagues such as Jeremy A. Freeman and Yi Li. These partnerships enhance the research and development efforts at Omeros Corporation.

Conclusion

William Jason Cummings is a distinguished inventor whose work in monoclonal antibodies has the potential to impact medical diagnostics and treatment. His contributions to the field exemplify the importance of innovation in biotechnology.